Class / Patent application number | Description | Number of patent applications / Date published |
514143000 | Ester of (HX)P=X(XH)(XH) (X is chalcogen) (e.g., phosphate, etc.) | 32 |
20090023688 | Microbicidal composition - Synergistic microbicidal compositions containing N-methyl-1,2-benzisothiazolin-3-one. | 01-22-2009 |
20090029951 | CALCIUM/SODIUM SALT OF INOSITOL TRIPYROPHOSPHATE AS AN ALLOSTERIC EFFECTOR OF HEMOGLOBIN - The present invention relates to mixed calcium/sodium salt of inositol tripyrophosphate, methods of preparing and methods of use. The mixed calcium/sodium salt may be a monocalcium tetrasodium salt of inositol tripyrophosphate. Methods of use include administering the above salts in an effective amount to treat diseases caused by hypoxia or other conditions associated with inadequate function of the lungs or circulatory system, such as various types of cancer and Alzheimer's disease. | 01-29-2009 |
20100035844 | PESTICIDE COMPOSITION COMPRISING PROPAMOCARB-FOSETYLATE AND AN INSECTICIDALLY ACTIVE SUBSTANCE - The present invention relates to a pesticide composition intended for protecting plants, crops or seeds against phyto-pathogenic fungi or damaging insects, and the corresponding methods of treatment using the said composition. More precisely, the subject of the present invention is a pesticide composition based on propamocarb-fosetylate, an insecticide active substance and optionally a further fungicide active substance. | 02-11-2010 |
20100048516 | PENETRATION ENHANCER FOR FUNGICIDES - The invention relates to the field of chemical plant protection, in particular the use of a specific compound as a penetration enhancer for agrochemical active substances selected from the group consisting of the herbicides and safeners. The compound is tributoxyethyl phosphate (TBEP). | 02-25-2010 |
20100063007 | PESTICIDE COMPOSITION COMPRISING FOSETYL-ALUMINUM AND AN INSECTICIDE ACTIVE SUBSTANCE - The present invention relates to a pesticide composition intended for protecting plants, crops or seeds against phyto-pathogenic fungi or damaging insects, and the corresponding methods of treatment using the said composition. More precisely, the subject of the present invention is a pesticide composition based on fosetyl-Al, an insecticide active substance and optionally a further fungicide active substance. | 03-11-2010 |
20100137260 | COMPOUND FOR INHIBITING TRPV3 FUNCTION AND USE THEREOF - The present invention relates to a TRPV3 (transient receptor potential vanilloid 3) activity inhibitor, more precisely to a method for inhibiting TRPV3 activity including the step of treating isopentenyl pyrophosphate and a method for treating skin disease containing the step of administering isopentenyl pyrophosphate to a subject with skin disease or applying the same on the skin of the subject. Isopentenyl pyrophosphate of the present invention controls increase of sensory cell reactivity to current or migration and proliferation of skin cells induced by TRPV3, so that it can be effectively used for the development of a pain reliever or a therapeutic agent for skin disease. | 06-03-2010 |
20100197638 | Skin Beautifying Agent - The present invention aims to provide a skin-beautifying agent, food, beverage, or feed for skin-beautification which has cosmetic effects such as moisturizing and beautifying the skin as well as preventing skin roughness and wrinkles by oral intake. The present invention further aims to provide a skin-beautifying agent containing a milk-derived phospholipid as an effective ingredient, and to provide food, beverage, or feed for skin-beautification containing the skin-beautifying agent. The milk-derived phospholipid is preferably a composition prepared from milk or milk material containing 40 to 70% by weight of lipid in a total solid content and containing 30% or more by weight of milk-derived phospholipid. | 08-05-2010 |
20100197639 | Methods and Devices for Analysis of X-Ray Images - The present invention relates to methods and devices for analyzing x-ray images. In particular, devices, methods and algorithms are provided that allow for the accurate and reliable evaluation of bone structure from x-ray images. | 08-05-2010 |
20100210601 | FLEA CONTROL METHOD - This invention relates to a method of controlling or preventing maturation of fleas on an animal or its environment comprising applying to a warm blooded animal or its environment a composition comprising an developmentally disruptive amount of a compound of Formula 1 or an N-oxide, or a salt thereof. | 08-19-2010 |
20100240617 | BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS - Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors. | 09-23-2010 |
20110144064 | Inhibitors of Kynurenine Aminotransferase and Uses Therefor - Provided herein are methods of decreasing a level of kynurenic acid in a cell and of treating a pathophysiological condition in a subject associated with an increase in kynurenic acid in a subject. In these methods the inhibitory action of dicarboxylic acids or derivatives or analogs thereof are effective to inhibit activity of kynurenine aminotransferase II. Also provided is a method of screening for potential inhibitory compounds for kynurenine aminotransferase II. The dicarboxylic acids or derivatives or analogs thereof may have the structural formula, where R | 06-16-2011 |
20110263539 | SHIP 1 MODULATOR COMPOUNDS - The present invention provides the use of pelorol analogs of Formula, (I) and pharmaceutical compositions thereof as modulators of SHIP 1 activity. A compound or a pharmaceutical composition of the present invention may be used for the treatment or prophylaxis of an inflammatory, neoplastic, hematopoetic or immune disorder or condition in addition to other disorders and conditions. | 10-27-2011 |
20120258936 | INOSITOL HEXAKISPHOSPHATE ANALOGS AND USES THEREOF - Provided herein are analog and derivative compounds of inositol hexakisphosphate effective to treat a | 10-11-2012 |
20120264720 | IDENTIFICATION AND TREATMENT OF CANCER SUBSETS - Methods of predicting whether or not a tumor will be responsive to IP6 treatment, methods of treating patients with cancer using IP6, methods of predicting the progression of a disease, and kits that facilitate these methods are disclosed. | 10-18-2012 |
20140045799 | INOSITOL HEXAKISPHOSPHATE ANALOGS AND USES THEREOF - Provided herein are analog and derivative compounds of inositol hexakisphosphate effective to treat a | 02-13-2014 |
20180020668 | Agricultural Mixtures | 01-25-2018 |
514144000 | Triester | 8 |
20090075947 | DEUTERIUM-ENRICHED FOSPROPOFOL - The present application describes deuterium-enriched fospropofol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 03-19-2009 |
20100261682 | Method and Means for the Treatment of Cachexia - The present invention relates to the treatment of cachexia in a mammal by the use of a compound comprising a high density negatively charged domain of vicinally oriented radicals. | 10-14-2010 |
20110312917 | CLEANING COMPOSITION FOR TREATING TISSUE FOR TRANSPLANTATION DERIVED FROM HUMAN/ANIMAL - The present invention relates to a cleaning composition for removing cellular components from tissue for transplantation derived from humans and animals. More particularly, the present invention relates to a cleaning composition for treating tissue for transplantation comprising a polyoxyethyleneglycol C | 12-22-2011 |
514145000 | Three benzene rings bonded directly to chalcogen | 1 |
20100168069 | INSECT REPELLENT - The invention provides an insect repellent composition that repels flies, gnats, mosquitoes, lice, ticks, and fleas. The insect repellent composition includes an effective amount of a phosphorous containing compound having the formula (RO) | 07-01-2010 |
514147000 | One benzene ring bonded directly to chalcogen | 4 |
20080255071 | Synergistic Fungicidal Active Compound Combinations - The novel active compound combinations comprising a carboxamide of the general formula (I) (group 1) | 10-16-2008 |
20100069337 | BUTYRYLCHOLINESTERASE INHIBITORS - Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases. | 03-18-2010 |
20120129815 | FUNGICIDAL COMPOSITION - A fungicidal composition comprising tolclofos-methyl, polyoxyethylene polyarylphenol phosphate, polyoxylethylene polyoxypropylene block copolymer, polyoxyethylene fatty alcohol ether and water has good stability of the formulation at high temperature. | 05-24-2012 |
20140073608 | Butyrylcholinesterase Inhibitors - Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. | 03-13-2014 |
514148000 | Diester | 8 |
20080207568 | Class of Gamma Delta T Cells Activators and Use Thereof - The present invention relates to a new class of compounds having γδ T cells activating properties referred to herein as angelyl or tiglyl phosphoesters, compositions comprising any of these compounds and methods for regulating an immune response in a subject comprising the step of administering these compounds. | 08-28-2008 |
20080306028 | Erianin Salts, Their Preparation Methods and Pharmaceutical Compositions Containing the Same - This invention relates to a kind of Erianin salt and the preparing process thereof. The said Erianin salt is a compound with the following general formula (I), wherein R is the salt formed by monobasic acid radical of inorganic oxacid combining with metals, ammonium salts, organic amine. This invention also relates to a pharmaceutical composition comprising Erianin salt. Compared with Erianin, the said Erianin salt has far better solubility, which can improve the bioavailability and show better antineoplastic efficacy. | 12-11-2008 |
20080318909 | Use Of Linoleic Compounds Against Heart Failure - Linoleic acid and related cardiolipin products are used as dietary supplements that provide cardiac benefits against a variety of cardiac related symptoms and diseases. For example, the disclosed compositions and methods may be used to treat or prevent hypertension, ischemic cardiomyopathy, heart disease, Barth Syndrome and heart failure. | 12-25-2008 |
20100222306 | Class of Gamma Delta T Cells Activators and Use Thereof - The present invention relates to a new class of compounds having γδ T cells activating properties referred to herein as angelyl or tiglyl phosphoesters, compositions comprising any of these compounds and methods for regulating an immune response in a subject comprising the step of administering these compounds. | 09-02-2010 |
20110003775 | COMPOSITION AND METHOD FOR PROMOTING SURVIVAL OF AGED BASAL FOREBRAIN CHOLINERGIC NEURON LEADING TO PROVENTION AND TREATMENT OF AGE-RELATED NEURODEGENERATIVE DISORDER - A method of treating a subject and preventing in a subject age-dependent basal forebrain cholinergic dysfunction related neurodegenerative disorders, comprising: administering a lipid composition comprising a therapeutically effective amount of highly enriched 1-acyl chains/2-docosahexaenoic acid containing molecular species of highly pure phospholipids to promote survival of aged basal forebrain cholinergic neurons, the phospholipids selected from the group consisting of phosphatidylserine, phosphatidylethanolamine, and phosphatidyl-monomethylethanolamine. A composition for treating a subject and preventing in a subject age-dependent basal forebrain cholinergic dysfunction related neurodegenerative disorders, the composition comprising: a lipid composition comprising: a therapeutically effective amount of highly enriched 1-acyl chains/2-docosahexaenoic acid containing molecular species of highly pure phospholipids to promote survival of aged basal forebrain cholinergic neurons, the phospholipids selected from the group consisting of phosphatidylserine, phosphatidylethanolamine, and phosphatidyl-monomethylethanolamine. A process for preparing a lipid composition comprising a therapeutically amount of natural source-based highly enriched 1-acyl chains/2-docosahexaenoic acid containing molecular species of highly pure phosphatidylserine to promote survival of aged basal forebrain cholinergic neurons; the process comprising: purifying a natural source-based phosphatidylcholine by silica chromatography; obtaining a related lysophosphatidylserine species by phospholipase A2 catalysis of transphosphatidylated natural source-based phosphatidylserine species; acylating the lysophosphatidylserine species with natural docosahexaenoic acid to form 1-acyl chains/2-docosahexaenoic acid containing phosphatidylserine species; and purifying the 1-acyl cgains/2-docosahexaenoic acid containing phosphatidylserine species by silica chromatography. | 01-06-2011 |
20130324499 | MOISTURISER BLEND - A blend for use in a personal care composition comprises a dialkyl amphiphilic component and an ester of a long chain branched fatty acid and a long chain branched alcohol. The blend can be pastillated and/or flaked, and can be used as the oil phase of an oil-in-water emulsion. The blend can be used in a moisturiser composition for moisturising skin. | 12-05-2013 |
20150038472 | USE OF THERAPEUTICALLY EFFECTIVE LIPIDS AND METHOD FOR PRODUCING ORGAN-/TISSUE-SPECIFIC THERAPEUTICALLY EFFECTIVE LIPIDS - The use of therapeutically active lipids for organ/tissue-specific enrichment for the treatment of inflammatory, ischemic or degenerative disorders and/or for stimulating a regeneration is arranged and developed such that the lipids are bound on application to carrier molecules for which cell-specific uptake systems in the cells of the organs and/or tissue exist. In addition, a method of producing organ/tissue-specific therapeutically active lipids for treatment of inflammatory, ischemic or degenerative disorders and/or stimulation of a regeneration, in particular for treating inflammatory liver disorders, is claimed, which is arranged and developed such that lysophosphatidylethanolamine (LysoPE) is coupled to the carboxyl group of ursodeoxycholate (UrsoDOCA) converted to an ester to give a LysoPE-DOCA compound. | 02-05-2015 |
20150111860 | SUSPOEMULSION - The present invention relates to a suspoemulsion comprising the following ingredients (1), (2), (3), (4), (5), and (6):
| 04-23-2015 |